Mycea at CIMA 2025 International Conference : New biocontrol solutions from forest fungal extracts.

On December 4th, Mycea presented its scientific advances at the 14th International Conference on Plant Diseases (CIMA) in Angers. Organized by Végéphyl, this conference brings together researchers, technical institutes, and industry players.

The 2025 edition placed plant protection against diseases at the heart of discussions in the context of agroecological transition.

Mycea’s fungal unique extract library and platform approach validated at CIMA 2025

Mycea develops biocontrol solutions derived from forest fungi. Our approach is based on a proprietary collection of over 750 forest fungal strains, systematically screened for their potential against crop diseases.

Our method consists of screening, comparing, and prioritizing the most promising extracts according to strict criteria of efficacy, safety, and industrial viability,” explains Dominique Barry-Etienne, Science & Production CEO and co-founder of Mycea.

Dominique Barry-Etienne, Science & Production CEO, presenting Mycea’s biocontrol pipeline at CIMA 2025 — Angers, December 4th

A rigorous selection process

Our development pipeline follows a structured methodology:

  1. Initial validation: confirmation of mycelial extract efficacy in the laboratory
  2. Production: development of scalable liquid bio-production processes in bioreactors
  3. Characterization: identification and purification of active substances

Each phase integrates toxicological and ecotoxicological assessments aligned with OECD standards, enabling rapid identification of the most promising candidates.

Grapevine and potato downy mildew

Proven effectiveness in campo: protection comparable to market standards.


Presentation of French field trials results.


After two years of plant and field trials with Contract Research Organizations (CROs), our lead candidate demonstrates very promising preventive efficacy against grapevine downy mildew (P. viticola) and potato late blight (P. infestans)

.

These results were obtained with documented dose-response data and rigorous comparison against untreated controls and standard references.

The solution against downy mildew may already be beneath our feet, in forest ecosystems.

Download the full poster


This validation marks a key milestone in our 2026 roadmap.

Interested in Mycea’s biocontrol pipeline?
Discover our investment opportunity.

Key takeways 750+ proprietary forest fungal strains screened Preventive efficacy comparable to market standards (P. viticola, P. infestans) 2-year field trials with accredited CROs — dose-response data available

Other News

mycea_echos
Mycea in Les Échos - a leading French national business newspaper
Mycea is gaining recognition in the Ag Biotech ecosystem for its innovative approach to crop protection...
Pétri-Mycea-Region
MYCEA in La Lettre M, a regional economic newsletter.
In its January 7th edition, the business monthly La Lettre M highlights our development strategy and...